13.01
+5.17%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sichuan Goldstone Asia Pharmaceutical
Its shares trade on Shenzhen under the ticker 300434.SZ. It has been listed since 24 April 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.04bn and net income of CN¥131.6m. At that date it held total assets of CN¥3.23bn and shareholders' equity of CN¥2.55bn.
Sichuan Goldstone Asia Pharmaceutical, Inc. engages in the research and development and application of steel reinforced plastic composite pipe technology and machinery. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2015-04-24. Its main products include health products, cracks and small cracks. The firm is also engaged in the machinery manufacturing business, as well as property leasing and management business. Its machinery products mainly include steel reinforced plastic pipe production line, bead winding steel reinforced pipe production line, production line equipment parts and other equipment. The firm mainly operates its businesses in domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 24 Apr 2015
- Employees
- 1,878
- Website
- goldstone-group.com ↗
Leadership
Pay as last reported
- Mr. Yiping MaChairman of the Board, President, General Manager, since 2023
- Mr. Yixi KuaiVice Chairman of the Board, since 2014
- Mr. Jin LouVice Chairman of the Board, since 2017
- Mr. Qingguo WangChief Financial Officer
- Mr. Qiang LinVice President, Deputy General Manager, Secretary of the Board, Director, since 2011
- Dr. Xiaoxia ShengVice President, Deputy General Manager, Director, since 2020
- Mr. Zhihao WangVice President, Deputy General Manager
- Ms. Liu YangStaff Elected Director
- Mr. Zhiyong ZhengDirector
- Mr. Youlong JiaIndependent Director
- Mr. Chuwang LiuIndependent Director
- Ms. Xiaowei ZhaoIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Sichuan Goldstone Asia Pharmaceutical employs 1,878 full-time employees in Chengdu, China.
- The company's machinery products include steel reinforced plastic pipe production lines and related equipment.
- Health products and small cracks are key offerings in the pharmaceutical sector.
Weaknesses
- The company focuses solely on domestic market operations in China.
- Sichuan Goldstone Asia Pharmaceutical's machinery manufacturing business lacks international expansion.
- Health products and small cracks are limited in market reach.
Opportunities
- Expanding machinery manufacturing to international markets could boost growth.
- The domestic Chinese market offers potential for health product sales growth.
- Sichuan Goldstone Asia Pharmaceutical can leverage its machinery expertise for new applications.
Threats
- Competition from domestic pharmaceutical companies in China poses a risk.
- The machinery manufacturing sector faces economic downturns in China.
- Health product regulations may change, affecting market access.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.